[1]
|
中华医学会重症医学分会. 中国成人ICU镇痛和镇静治疗指南[J]. 中华危重病急救医学, 2018, 30(6): 497-514.
|
[2]
|
Chanques, G., Jaber, S., Barbotte, E., et al. (2006) Impact of Systematic Evaluation of Pain and Agitation in an Intensive Care Unit. Critical Care Medicine, 34, 1691-1699. https://doi.org/10.1097/01.CCM.0000218416.62457.56
|
[3]
|
Tate, J.A., Devito Dabbs, A., Hoffman, L.A., et al. (2012) Anxiety and Agitation in Mechanically Ventilated Patients. Qualitative Health Research, 22, 157-173. https://doi.org/10.1177/1049732311421616
|
[4]
|
中华医学会重症医学分会. 中国重症加强治疗病房患者镇痛和镇静治疗指导意见(2006) [J]. 中华外科杂志, 2006(17): 1158-1166.
|
[5]
|
Devlin, J.W., Skrobik, Y., Gélinas, C., et al. (2018) Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immo-bility, and Sleep Disruption in Adult Patients in the ICU. Critical Care Medicine, 46, E825-E873. https://doi.org/10.1097/CCM.0000000000003299
|
[6]
|
Mirrakhimov, A.E., Voore, P., Halytskyy, O., Khan, M. and Ali, A.M. (2015) Propofol Infusion Syndrome in Adults: A Clinical Update. Critical Care Research and Practice, 2015, Article ID: 260385.
https://doi.org/10.1155/2015/260385
|
[7]
|
Saari, T.I., Uusi-Oukari, M., Ahonen, J. and Olkkola, K.T. (2011) En-hancement of GABAergic Activity: Neuropharmacological Effects of Benzodiazepines and Therapeutic Use in Anesthe-siology. Pharmacological Reviews, 63, 243-267.
https://doi.org/10.1124/pr.110.002717
|
[8]
|
Kilpatrick, G.J., McIntyre, M.S., Cox, R.F., et al. (2007) CNS 7056: A Novel Ultrashort-Acting Benzodiazepine. Anesthesiology, 107, 60-66. https://doi.org/10.1097/01.anes.0000267503.85085.c0
|
[9]
|
Goudra, B.G. and Singh, P.M. (2014) Remimazolam: The Future of Its Sedative Potential. Saudi Journal of Anaesthesia, 8, 388-391. https://doi.org/10.4103/1658-354X.136627
|
[10]
|
Pambianco, D.J. and Cash, B.D. (2016) New Horizons for Seda-tion: the Ultrashort Acting Benzodiazepine Remimazolam. Techniques in Gastrointestinal Endoscopy, 18, 22-28. https://doi.org/10.1016/j.tgie.2016.02.004
|
[11]
|
Chen, X., Sang, N., Song, K., et al. (2020) Psychomotor Recovery Following Remimazolam-Induced Sedation and the Effectiveness of Flumazenil as an Antidote. Clinical Therapeutics, 42, 614-624.
https://doi.org/10.1016/j.clinthera.2020.02.006
|
[12]
|
Jacob, T.C., Moss, S.J. and Jurd, R. (2008) GABA(A) Re-ceptor Trafficking and Its Role in the Dynamic Modulation of Neuronal Inhibition. Nature Reviews Neuroscience, 9, 331-343. https://doi.org/10.1038/nrn2370
|
[13]
|
Freyer, N., Knöspel, F., Damm, G., et al. (2019) Metabolism of Remimazolam in Primary Human Hepatocytes during Continuous Long-Term Infusion in a 3-D Bioreactor System. Drug Design, Development and Therapy, 13, 1033-1047.
https://doi.org/10.2147/DDDT.S186759
|
[14]
|
Zhou, Y., Hu, P. and Jiang, J. (2017) Metabolite Characterization of a Novel Sedative Drug, Remimazolam in Human Plasma and Urine Using Ultra High-Performance Liquid Chromatog-raphy Coupled with Synapt High-Definition Mass Spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 137, 78-83.
https://doi.org/10.1016/j.jpba.2017.01.016
|
[15]
|
Antonik, L.J., Goldwater, D.R., Kilpatrick, G.J., et al. (2012) A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056): Part I. Safety, Efficacy, and Basic Pharmacokinetics. Anesthesia & Analgesia, 115, 274-283.
https://doi.org/10.1213/ANE.0b013e31823f0c28
|
[16]
|
Sheng, X.Y., Liang, Y., Yang, X.Y., et al. (2020) Safety, Pharmacokinetic and Pharmacodynamic Properties of Single Ascending Dose and Continuous Infusion of Remimazolam Besylate in Healthy Chinese Volunteers. European Journal of Clinical Pharmacology, 76, 383-391. https://doi.org/10.1007/s00228-019-02800-3
|
[17]
|
Schüttler, J., Eisenried, A., Lerch, M., et al. (2020) Pharmacoki-netics and Pharmacodynamics of Remimazolam (CNS 7056) After Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics. Anesthesiology, 132, 636-651. https://doi.org/10.1097/ALN.0000000000003103
|
[18]
|
Worthington, M.T., Antonik, L.J., Goldwater, D.R., et al. (2013) A Phase Ib, Dose-Finding Study of Multiple Doses of Remimazolam (CNS 7056) in Volunteers Undergoing Colonoscopy. Anesthesia & Analgesia, 117, 1093-1100.
https://doi.org/10.1213/ANE.0b013e3182a705ae
|
[19]
|
Pambianco, D.J., Borkett, K.M., Riff, D.S., et al. (2016) A Phase IIb Study Comparing the Safety and Efficacy of Remimazolam and Midazolam in Patients Undergoing Colonos-copy. Gastrointestinal Endoscopy, 83, 984-992.
https://doi.org/10.1016/j.gie.2015.08.062
|
[20]
|
Rex, D.K., Bhandari, R., Desta, T., et al. (2018) A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared with Placebo and Midazolam in Patients Undergoing Colonoscopy. Gastrointestinal Endoscopy, 88, 427-437.e6. https://doi.org/10.1016/j.gie.2018.04.2351
|
[21]
|
Chen, S., Wang, J., Xu, X., et al. (2020) The Efficacy and Safety of Remimazolam Tosylate versus Propofol in Patients Undergoing Colonoscopy: A Multicentered, Randomized, Posi-tive-Controlled, Phase III Clinical Trial. American Journal of Translational Research, 12, 4594-4603.
|
[22]
|
Rex, D.K., Bhandari, R., Lorch, D.G., et al. (2021) Safety and Efficacy of Remimazolam in High Risk Colonoscopy: A Randomized Trial. Digestive and Liver Disease, 53, 94-101. https://doi.org/10.1016/j.dld.2020.10.039
|
[23]
|
Borkett, K.M., Riff, D.S., Schwartz, H.I., et al. (2015) A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy. Anesthesia & Analgesia, 120, 771-780. https://doi.org/10.1213/ANE.0000000000000548
|
[24]
|
Chen, S.H., Yuan, T.M., Zhang, J., et al. (2021) Remima-zolam Tosilate in Upper Gastrointestinal Endoscopy: A Multicenter, Randomized, Non-Inferiority, Phase III Trial. Jour-nal of Gastroenterology and Hepatology, 36, 474-481.
https://doi.org/10.1111/jgh.15188
|
[25]
|
Ichijima, R., Ikehara, H., Maeda, T., et al. (2022) The First Dose-Ranging Study of Remimazolam in Japanese Patients Undergoing Gastrointestinal Endoscopy: A Phase II Investigator-Initiated Clinical Trial. Digestive Endoscopy. (Preprint) https://doi.org/10.1111/den.14365
|
[26]
|
Pastis, N.J., Yarmus, L.B., Schippers, F., et al. (2019) Safety and Efficacy of Remimazolam Compared with Placebo and Midazolam for Moderate Sedation during Bronchoscopy. Chest, 155, 137-146.
https://doi.org/10.1016/j.chest.2018.09.015
|
[27]
|
贾真, 任丽霞, 范叶铁, 谭志明. 甲苯磺酸瑞马唑仑用于纤维支气管镜检查中深度镇静的有效剂量观察[J]. 中华医学杂志, 2021, 101(11): 813-816.
|
[28]
|
Zhang, X., Li, S. and Liu, J. (2021) Efficacy and Safety of Remimazolam Besylate versus Propofol during Hysteroscopy: Single-Centre Ran-domized Controlled Trial [Published Correction Appears in BMC Anesthesiol. 2021 Jun 18; 21, 173]. BMC Anesthesi-ology, 21, Article No. 156. https://doi.org/10.1186/s12871-021-01373-y
|
[29]
|
Zhang, S., Wang, J., Ran, R., Peng, Y. and Xiao, Y. (2022) Efficacy and Safety of Remimazolam Tosylate in Hysteroscopy: A Randomized, Single-Blind, Parallel Controlled Trial. Journal of Clinical Pharmacy and Therapeutics, 47, 55-60. https://doi.org/10.1111/jcpt.13525
|
[30]
|
Doi, M., Morita, K., Takeda, J., Sakamoto, A., Yamakage, M. and Suzuki, T. (2020) Efficacy and Safety of Remimazolam versus Propofol for General Anesthesia: A Multicenter, Single-Blind, Randomized, Parallel-Group, Phase IIb/III Trial. Journal of Anesthesia, 34, 543-553. https://doi.org/10.1007/s00540-020-02788-6
|
[31]
|
Dai, G., Pei, L., Duan, F., et al. (2021) Safety and Efficacy of Remimazolam Compared with Propofol in Induction of General Anesthesia. Minerva Anestesiologica, 87, 1073-1079.
|
[32]
|
Doi, M., Hirata, N., Suzuki, T., Morisaki, H., Morimatsu, H. and Sakamoto, A. (2020) Safety and Ef-ficacy of Remimazolam in Induction and Maintenance of General Anesthesia in High-Risk Surgical Patients (ASA Class III): Results of a Multicenter, Randomized, Double-Blind, Parallel-Group Comparative Trial. Journal of Anesthesia, 34, 491-501.
https://doi.org/10.1007/s00540-020-02776-w
|
[33]
|
Sato, T., Kato, Y., Yamamoto, M. and Nishiwaki, K. (2020) Novel Anesthetic Agent Remimazolam as an Alternative for the Asleep-Awake-Asleep Technique of Awake Craniotomy. JA Clinical Reports, 6, Article No. 92.
https://doi.org/10.1186/s40981-020-00398-5
|
[34]
|
Tachibana, S., Hayamizu, K. and Yamakage, M. (2021) Remi-mazolam Use for Awake Craniotomy. JA Clinical Reports, 7, Article No. 25. https://doi.org/10.1186/s40981-021-00428-w
|
[35]
|
Kondo, T., Toyota, Y., Narasaki, S., et al. (2020) Intraoperative Responses of Motor Evoked Potentials To the Novel Intravenous Anesthetic Remimazolam during Spine Surgery: A Report of Two Cases. JA Clinical Reports, 6, Article No. 97. https://doi.org/10.1186/s40981-020-00401-z
|
[36]
|
Saito, K., Ohno, S., Maeda, M., Hirata, N. and Yamakage, M. (2021) Remimazolam Anesthesia for Cardiac Surgery with Cardiopulmonary Bypass: A Case Report. JA Clinical Re-ports, 7, Article No. 21.
https://doi.org/10.1186/s40981-021-00424-0
|
[37]
|
Fukuda, M., Tachibana, S., Nishihara, N. and Yamakage, M. (2021) Remimazolam for a Patient with Myotonic Dystrophy Type 1 Who Underwent Endoscopic Retrograde Cholangi-opancreatography Under General Anesthesia: A Case Report. JA Clinical Reports, 7, Article No. 17. https://doi.org/10.1186/s40981-021-00422-2
|
[38]
|
Suzuki, Y., Doi, M. and Nakajima, Y. (2021) General Anesthe-sia with Remimazolam in a Patient with Mitochondrial Encephalomyopathy: A Case Report. JA Clinical Reports, 7, Arti-cle No. 51.
https://doi.org/10.1186/s40981-021-00454-8
|
[39]
|
Furuta, M., Ito, H. and Yamazaki, M. (2021) Anaesthetic Man-agement Using Remimazolam in a Patient with Severe Aortic Stenosis: A Case Report. BMC Anesthesiology, 21, Article No. 202.
https://doi.org/10.1186/s12871-021-01422-6
|
[40]
|
Nakayama, J., Ogihara, T., Yajima, R., Innami, Y. and Ouchi, T. (2021) Anesthetic Management of Super-Elderly Patients with Remimazolam: A Report of Two Cases. JA Clinical Re-ports, 7, Article No. 71.
https://doi.org/10.1186/s40981-021-00474-4
|
[41]
|
Arashiro, A., Shinzato, H., Kamizato, K. and Kakinohana, M. (2021) Spinal Fusion with Motor Evoked Potential Monitoring Using Remimazolam in Alström Syndrome: A Case Re-port. Medicine, 100, e27990.
https://doi.org/10.1097/MD.0000000000027990
|
[42]
|
叶冲冲, 谢永鹏, 骆继业, 陈晓兵, 王静, 陆思烨, 王言理. 不同剂量瑞马唑仑在ICU机械通气患者中的镇静效果及对血流动力学的影响[J]. 中国医药导报, 2021, 18(22): 121-124.
|
[43]
|
Kleiman, R.B., Darpo, B., Thorn, M., Stoehr, T. and Schippers, F. (2020) Potential Strategy for Assessing QT/QTc Interval for Drugs That Produce Rapid Changes in Heart Rate: Electrocardiographic Assessment of the Effects of Intravenous Remimazolam On Cardiac Repolarization. British Journal of Clinical Pharmacology, 86, 1600-1609.
https://doi.org/10.1111/bcp.14270
|
[44]
|
Schippers, F., Pesic, M., Saunders, R., et al. (2020) Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam versus Intravenous Midazolam and Placebo in Recrea-tional Central Nervous System Depressant Users. The Journal of Clinical Pharmacology, 60, 1189-1197. https://doi.org/10.1002/jcph.1614
|